Department of Radiology, Maastricht University Medical Center, the Netherlands.
AJNR Am J Neuroradiol. 2011 Mar;32(3):570-5. doi: 10.3174/ajnr.A2326. Epub 2011 Feb 24.
ISAT provided valuable data on patient outcome after endovascular coiling and surgical clipping of ruptured aneurysms. The purpose of this study was to retrospectively review the ≥1-year outcome (in terms of survival, independence, and rebleeding) of patients who were treated in a routine clinical setting.
Records of patients presenting with an SAH from a ruptured aneurysm between 2000 and 2008 were reviewed. The 403 patients who met the inclusion criteria harbored 443 treated aneurysms; 173 were managed surgically and 230 by endovascular means. Mean clinical follow-up was 33.9 months (range, 12-106 months).
The pretreatment clinical condition according to the HH was significantly better in the surgically treated patients (P = .018). Death occurred in 11.6% after surgery and in 17.4% after endovascular treatment (P = .104). Of the surviving patients in the surgical and endovascular groups, 80.3% and 87.2%, respectively, were able to live independently with grades 0-2 on the mRS (P = .084). Complete aneurysm occlusion was achieved significantly more often after surgical treatment (P < .001). Rebleeding occurred in 3.1% and 2.3% of the patients after surgical treatment and endovascular coiling, respectively. The occurrence of a residual aneurysm at the end of a coiling procedure was significantly related to the frequency of rebleeding (P = .007).
The management of patients with intracranial aneurysms in a routine clinical setting shows good and comparable rates of mortality and independence. Coiling results in lower rates of complete aneurysm occlusion. Postcoiling angiography showing a residual aneurysm is a good predictor of the risk of rebleeding.
ISAT 提供了有关血管内线圈栓塞和手术夹闭破裂动脉瘤后患者结局的有价值数据。本研究旨在回顾性分析在常规临床环境中治疗的患者的≥1 年结局(包括生存、独立和再出血)。
回顾了 2000 年至 2008 年间因蛛网膜下腔出血就诊的患者的记录。符合纳入标准的 403 例患者中,443 例存在破裂的动脉瘤,其中 173 例接受手术治疗,230 例接受血管内治疗。平均临床随访时间为 33.9 个月(范围 12-106 个月)。
根据 HH 评估,手术治疗患者的术前临床状况明显更好(P=0.018)。手术治疗后死亡发生率为 11.6%,血管内治疗后为 17.4%(P=0.104)。在手术组和血管内组中幸存的患者中,分别有 80.3%和 87.2%能够独立生活,mRS 评分 0-2 分(P=0.084)。手术治疗后完全闭塞动脉瘤的比例明显更高(P<0.001)。手术治疗和血管内线圈栓塞后患者的再出血发生率分别为 3.1%和 2.3%。线圈栓塞后残余动脉瘤的存在与再出血的频率显著相关(P=0.007)。
在常规临床环境中治疗颅内动脉瘤的患者,死亡率和独立性的预后良好且相似。线圈栓塞可降低完全闭塞动脉瘤的比例。线圈栓塞后血管造影显示残余动脉瘤是再出血风险的良好预测指标。